Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC34385103378;103379;103380 chr2:178533462;178533461;178533460chr2:179398189;179398188;179398187
N2AB3274498455;98456;98457 chr2:178533462;178533461;178533460chr2:179398189;179398188;179398187
N2A3181795674;95675;95676 chr2:178533462;178533461;178533460chr2:179398189;179398188;179398187
N2B2532076183;76184;76185 chr2:178533462;178533461;178533460chr2:179398189;179398188;179398187
Novex-12544576558;76559;76560 chr2:178533462;178533461;178533460chr2:179398189;179398188;179398187
Novex-22551276759;76760;76761 chr2:178533462;178533461;178533460chr2:179398189;179398188;179398187
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: R
  • RefSeq wild type transcript codon: AGA
  • RefSeq wild type template codon: TCT
  • Domain: Ig-162
  • Domain position: 23
  • Structural Position: 34
  • Q(SASA): 0.2539
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
R/I rs1369995123 -0.49 0.999 D 0.726 0.514 0.73428325888 gnomAD-2.1.1 4.02E-06 None None None None I None 0 0 None 0 0 None 3.27E-05 None 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
R/A 0.9751 likely_pathogenic 0.962 pathogenic -1.315 Destabilizing 0.992 D 0.547 neutral None None None None I
R/C 0.8465 likely_pathogenic 0.7718 pathogenic -1.289 Destabilizing 1.0 D 0.681 prob.neutral None None None None I
R/D 0.9953 likely_pathogenic 0.992 pathogenic -0.324 Destabilizing 0.999 D 0.701 prob.neutral None None None None I
R/E 0.9605 likely_pathogenic 0.9425 pathogenic -0.123 Destabilizing 0.992 D 0.475 neutral None None None None I
R/F 0.9875 likely_pathogenic 0.9795 pathogenic -0.636 Destabilizing 1.0 D 0.709 prob.delet. None None None None I
R/G 0.9703 likely_pathogenic 0.9513 pathogenic -1.693 Destabilizing 0.994 D 0.655 neutral N 0.506065217 None None I
R/H 0.7228 likely_pathogenic 0.6043 pathogenic -1.653 Destabilizing 1.0 D 0.657 neutral None None None None I
R/I 0.9402 likely_pathogenic 0.9187 pathogenic -0.252 Destabilizing 0.999 D 0.726 prob.delet. D 0.522477191 None None I
R/K 0.665 likely_pathogenic 0.5589 ambiguous -1.076 Destabilizing 0.543 D 0.269 neutral N 0.459809792 None None I
R/L 0.9088 likely_pathogenic 0.876 pathogenic -0.252 Destabilizing 0.996 D 0.655 neutral None None None None I
R/M 0.9612 likely_pathogenic 0.9399 pathogenic -0.756 Destabilizing 1.0 D 0.71 prob.delet. None None None None I
R/N 0.9912 likely_pathogenic 0.9832 pathogenic -0.866 Destabilizing 0.999 D 0.632 neutral None None None None I
R/P 0.9955 likely_pathogenic 0.9936 pathogenic -0.589 Destabilizing 1.0 D 0.709 prob.delet. None None None None I
R/Q 0.676 likely_pathogenic 0.5631 ambiguous -0.821 Destabilizing 0.998 D 0.621 neutral None None None None I
R/S 0.9836 likely_pathogenic 0.9735 pathogenic -1.735 Destabilizing 0.989 D 0.624 neutral D 0.523687912 None None I
R/T 0.9598 likely_pathogenic 0.9404 pathogenic -1.315 Destabilizing 0.998 D 0.703 prob.neutral N 0.518722023 None None I
R/V 0.9512 likely_pathogenic 0.9343 pathogenic -0.589 Destabilizing 0.999 D 0.709 prob.delet. None None None None I
R/W 0.8686 likely_pathogenic 0.8044 pathogenic -0.149 Destabilizing 1.0 D 0.652 neutral None None None None I
R/Y 0.9747 likely_pathogenic 0.9585 pathogenic 0.032 Stabilizing 1.0 D 0.713 prob.delet. None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.